This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Natick, MA and founded in 1979, Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments viz. Cardiovascular (39.6% of total revenue in 2019; up 10% organically from 2018), Rhythm and Neuro (28.1%; up 1%) and MedSurg (30.2%; up 10.6%).
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System
by Zacks Equity Research
Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.
Reasons to Add ABT Stock to Your Portfolio Right Now
by Zacks Equity Research
Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.
RMD Stock Benefits From the Launch of NightOwl Across US
by Zacks Equity Research
Resmed launches NightOwl, an FDA-cleared home sleep apnea test, in the United States to diagnose OSA at home.
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
by Zacks Equity Research
DXCM continues to raise investor optimism due to its strong product portfolio.
Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM
by Zacks Equity Research
TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.
Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know
by Zacks Equity Research
Boston Scientific (BSX) concluded the recent trading session at $98.50, signifying a -1.55% move from its prior day's close.
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business
by Zacks Equity Research
McKesson acquires 80% ownership in PRISM Vision Holdings, diversifying its business into the high-growth area of ophthalmology. The deal is to be accretive this year.
Global Expansion in EPD and Innovations Support Abbott Stock
by Zacks Equity Research
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
by Zacks Equity Research
ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.
AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands
by Zacks Equity Research
ANGO reports solid fiscal third-quarter earnings with continued strength in its Med Tech segment. The expansion of gross margin bodes well.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?
by Zacks Equity Research
BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?
by Zacks Equity Research
BIO continues to attract investors' attention due to its robust performance in the ddPCR platform.
ALC Stock May Rise With the Introduction of PanOptix Pro in US
by Zacks Equity Research
Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
by Zacks Equity Research
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst
by Zacks Equity Research
Milestone Pharmaceuticals faces an FDA setback for its PSVT nasal spray. The company coordinates with regulatory authorities to resolve CRL issues.
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
by Urmimala Biswas
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
VEEV Stock Slips Despite New Research Site Clinical Trial System
by Zacks Equity Research
Veeva introduces a Research Site Clinical Trial Management System to streamline trial operations, enhance collaboration, and accelerate clinical research efficiency.
LH Stock to Gain From Launch of HPV and STI Self-Collection Options
by Zacks Equity Research
Labcorp launches self-collection options for HPV and STI testing in its PSCs.
ALGN Stock Gains From the Invisalign System With Mandibular Advancement
by Zacks Equity Research
Align Technology's Invisalign System, featuring mandibular advancement with occlusal blocks, is now commercially available for Class II malocclusion in the growing number of patients.
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
by Zacks Equity Research
RVTY's strong product portfolio raises optimism about the stock.
Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now?
by Zacks Equity Research
TMO continues to hold on to investors' attention due to its value-added acquisitions and trusted end-market channels.
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm
by Zacks Equity Research
GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.
GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech
by Zacks Equity Research
GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.
ABT Stock to Gain From Early CE Mark Approval of Volt PFA System
by Zacks Equity Research
Abbott achieves early CE Mark approval for the Volt PFA system.